Keryx Biopharmaceuticals (KERX)

Create an Alert
8.24 +0.58  +7.57%   NASDAQ Jun 19, 5:00PM BATS Real time Currency in USD

Keryx Biopharmaceuticals News

Litigation Settlements, Data Compliance Reviews, and Clinical Trials Pave Way for Solid Footing in Healthcare - Research Report on Pfizer, Merck, Bristol-Myers Squibb, Keryx and Pacira Pharmaceuticals
PR Newswire Jun 17

NEW YORK, June 17, 2013 /PRNewswire/ -- Today, Wall Street Reports announced new research reports highlighting Pfizer Inc. (NYSE: PFE), Merck & Co. Inc. (NYSE: MRK), Bristol-Myers Squibb Company (NYSE: ...

Five Best-Performing Biotech Stocks of 2013 (Some May Surprise You)
Jun 11

In a bubbly year for the biotech sector, these five stocks stand out over the rest.

Biotech Stock Mailbag: 2013 Clinical Trials Calendar
Jun 7

Biotech columnist Adam Feuerstein answers readers' questions about healthcare companies.

Keryx Biopharmaceuticals, Inc. Announces Zerenex™ Phase 3 Data Presented at the 2013 World Congress of Nephrology
PR Newswire Jun 3

NEW YORK, June 3, 2013 /PRNewswire/ -- Keryx Biopharmaceuticals, Inc. (Nasdaq: KERX) today announced the presentation of updated efficacy and safety data from the Phase 3 long-term clinical trial of Zerenex ...

Commit To Buy Keryx Biopharmaceuticals At $5, Earn 26%
May 31

Investors considering a purchase of Keryx Biopharmaceuticals Inc. shares, but tentative about paying the going market price of $8.14/share, might benefit from considering selling puts among the alternative strategies at their disposal.

Get News for

Recent Quotes

Symbol Price Chg Chg % Market Cap
KERX 8.24 +0.58 +7.57% 673.36M
Create Watchlist from Quotes

Access watchlists and custom data alerts.
Start your free account.

Registering enables you to view unlimited pages per month.

required
required
required
required
Get Started Now

Already registered? Sign in here.

document.write('');